Steven Cohen’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-51,252
| Closed | -$133K | – | 4394 |
|
|
2025
Q4 | $133K | Buy |
+51,252
| New | +$103K | ﹤0.01% | 3705 |
|
|
2023
Q4 | – | Sell |
-122,300
| Closed | -$1.48M | – | 2722 |
|
|
2023
Q3 | $1.48M | Buy |
+122,300
| New | +$1.26M | ﹤0.01% | 1214 |
|
|
2022
Q1 | – | Sell |
-28,500
| Closed | -$601K | – | 1360 |
|
|
2021
Q4 | $601K | Sell |
28,500
-31,198
| -52% | -$735K | ﹤0.01% | 956 |
|
|
2021
Q3 | $1.57M | Buy |
+59,698
| New | +$1.93M | 0.01% | 806 |
|
|
2021
Q2 | – | Sell |
-100,000
| Closed | -$3.07M | – | 1142 |
|
|
2021
Q1 | $3.07M | Sell |
100,000
-202,584
| -67% | -$6.88M | 0.01% | 666 |
|
|
2020
Q4 | $10.4M | Buy |
+302,584
| New | +$9.04M | 0.05% | 435 |
|
|
2020
Q3 | – | Sell |
-15,000
| Closed | -$465K | – | 1078 |
|
|
2020
Q2 | $465K | Buy |
+15,000
| New | +$482K | ﹤0.01% | 717 |
|
Steven Cohen's RPTX Position: Q1 2026 in Review
Steven Cohen sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 51,252 shares — an estimated $133K sold.
Steven Cohen first reported a position in RPTX in Q2 2020 and held it in 7 quarters. The position peaked at $10.4M in Q4 2020. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.
- Steven Cohen reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
- Steven Cohen sold 51,252 Repare Therapeutics shares in Q1 2026, an estimated $133K.
- Steven Cohen first reported a position in Repare Therapeutics in Q2 2020 and held it in 7 quarters.
- Steven Cohen's Repare Therapeutics position peaked at $10.4M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.
Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.